These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17041888)

  • 21. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells.
    Semba S; Itoh N; Ito M; Harada M; Yamakawa M
    Clin Cancer Res; 2002 Jun; 8(6):1957-63. PubMed ID: 12060641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor.
    Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
    J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment.
    Su JD; Mayo LD; Donner DB; Durden DL
    Cancer Res; 2003 Jul; 63(13):3585-92. PubMed ID: 12839945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance.
    Tanno S; Yanagawa N; Habiro A; Koizumi K; Nakano Y; Osanai M; Mizukami Y; Okumura T; Testa JR; Kohgo Y
    Cancer Res; 2004 May; 64(10):3486-90. PubMed ID: 15150102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
    Furuya F; Lu C; Willingham MC; Cheng SY
    Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma.
    Guillard S; Clarke PA; Te Poele R; Mohri Z; Bjerke L; Valenti M; Raynaud F; Eccles SA; Workman P
    Cell Cycle; 2009 Feb; 8(3):443-53. PubMed ID: 19177002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway.
    Poh TW; Pervaiz S
    Cancer Res; 2005 Jul; 65(14):6264-74. PubMed ID: 16024628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
    Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
    Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.
    Lu J; Zhuang Z; Song DK; Mehta GU; Ikejiri B; Mushlin H; Park DM; Lonser RR
    J Neurosurg; 2010 Aug; 113(2):225-33. PubMed ID: 20001590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.
    Fujiwara K; Iwado E; Mills GB; Sawaya R; Kondo S; Kondo Y
    Int J Oncol; 2007 Oct; 31(4):753-60. PubMed ID: 17786305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3'-kinase signaling pathway.
    Chrysis D; Zaman F; Chagin AS; Takigawa M; Sävendahl L
    Endocrinology; 2005 Mar; 146(3):1391-7. PubMed ID: 15576458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway.
    Tabellini G; Tazzari PL; Bortul R; Billi AM; Conte R; Manzoli L; Cocco L; Martelli AM
    Br J Haematol; 2004 Aug; 126(4):574-82. PubMed ID: 15287952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.
    Vallbo C; Bergenheim T; Hedman H; Henriksson R
    J Neurooncol; 2002 Jan; 56(2):143-8. PubMed ID: 11995815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT.
    Efron PA; Chen MK; Iyengar M; Dai W; Nagaram A; Beierle EA
    J Pediatr Surg; 2006 Jun; 41(6):1072-80. PubMed ID: 16769337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
    MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
    Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Src activation regulates anoikis in human colon tumor cell lines.
    Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
    Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
    Pollack IF; Kawecki S; Lazo JS
    J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.